Azacitidine 100 MG Injection — RxCUI 485246
RxNorm drug concept · Semantic clinical drug
RxCUI 485246
Semantic clinical drug · SCD
● Current RxNorm concept 26 FDA products
26 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI485246
Official nameAzacitidine 100 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped26
Package NDCs mapped26
Reported Medicaid activity (SDUD)14,177 prescriptions · 42 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Azacitidine Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's a chemotherapy used to treat a group of bone marrow disorders called myelodysplastic syndromes, or MDS. In MDS, the bone marrow doesn't produce healthy blood cells properly. A...
- What exactly is azacitidine injection used for?
- Azacitidine is given by a healthcare professional — either as a shot just under the skin (subcutaneous) or through an IV (into a vein). The typical schedule is once a day for 7 day...
- How is this medicine given, and how often will I need to come in?
🕸️ Concept Web — How Azacitidine 100 MG Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Azacitidine 100 MG Injection
RxCUI 485246 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Azacitidine
1251IN
-
Azacitidine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Vidaza
545203BN
-
Vidaza
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Azacitidine Injection
1726497SCDF -
Azacitidine Injectable Product
1154999SCDG -
Azacitidine Injection [Vidaza]
1726500SBDF -
Vidaza Injectable Product
1186581SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Azacitidine Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Azacitidine 100 MG
1726496SCDC -
Azacitidine 100 MG Injection [Vidaza]
545206SBD -
Azacitidine 100 MG [Vidaza]
1726499SBDC
-
Azacitidine 100 MG
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Azacitidine 100 MG
SCDC · 1726496 -
Azacitidine Injection
SCDF · 1726497 -
Azacitidine Injectable Product
SCDG · 1154999
Brand-Name Concepts
-
Azacitidine 100 MG Injection [Vidaza]
SBD · 545206 -
Azacitidine 100 MG [Vidaza]
SBDC · 1726499 -
Azacitidine Injection [Vidaza]
SBDF · 1726500 -
Vidaza Injectable Product
SBDG · 1186581 -
Vidaza
BN · 545203
📦 FDA Products & Package NDCs
26 products · 26 package NDCs
26 package NDCs map to RxCUI 485246 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00143-9606-01 | 1 VIAL in 1 CARTON (0143-9606-01) / 1 INJECTION, POWDER, LY... | Azacitidine | Hikma Pharmaceuticals USA Inc. | 2020-06-08 |
| 00781-3491-94 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (... | Azacitidine | Sandoz Inc | 2024-11-01 |
| 16714-0927-01 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (... | Azacitidine | NorthStar RxLLC | 2019-05-08 |
| 16729-0306-10 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (... | Azacitidine | Accord Healthcare Inc. | 2019-01-09 |
| 31722-0365-31 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (... | Azacitidine | Camber Pharmaceuticals, Inc. | 2024-10-15 |
| 43598-0305-62 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (... | Azacitidine | Dr. Reddy's Laboratories Inc. | 2013-09-19 |
| 43598-0465-62 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (... | Azacitidine | Dr. Reddy's Laboratories Inc. | 2015-06-19 |
| 43598-0678-11 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (... | AZACITIDINE AZACITIDINE | Dr. Reddy's Laboratories Inc. | 2017-12-13 |
| 43817-0906-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (43817-906-01) / 50 mL in 1... | Azacitidine | Panacea Biotec Limited | 2019-05-06 |
| 55150-0393-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-393-01) / 4 mL in 1... | AZACITIDINE | Eugia US LLC | 2023-01-03 |
| 58458-0002-02 | 1 VIAL, GLASS in 1 CARTON (58458-002-02) / 1 INJECTION, POW... | Azacitidine | Reliance Life Sciences Private Limited | 2025-07-30 |
| 59572-0102-01 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (... | VIDAZA | Celgene Corporation | 2004-07-05 |
| 60505-6271-01 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (... | Azacitidine | Apotex Corp | 2024-01-23 |
| 63323-0771-39 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-771-39) / 30 mL in 1... | Azacitidine | Fresenius Kabi USA, LLC | 2017-03-16 |
| 68001-0313-56 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (... | Azacitidine | BluePoint Laboratories | 2017-07-01 |
| 68001-0527-54 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (... | Azacitidine | BluePoint Laboratories | 2022-02-15 |
| 68001-0620-54 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (... | Azacitidine | BluePoint Laboratories. | 2025-01-10 |
| 69539-0112-01 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (... | Azacitidine | MSN LABORATORIES PRIVATE LIMITED | 2024-05-18 |
| 70069-0857-01 | 1 VIAL, GLASS in 1 CARTON (70069-857-01) / 1 INJECTION, POW... | Azacitidine | Somerset Therapeutics LLC | 2025-08-29 |
| 70121-1237-01 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (... | AZACITIDINE | Amneal Pharmaceuticals LLC | 2022-02-09 |
| 71288-0115-30 | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-115-30) / 1 INJECTIO... | Azacitidine | Meitheal Pharmaceuticals Inc. | 2020-11-02 |
| 71288-0153-95 | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-153-95) / 1 INJECTIO... | Azacitidine | Meitheal Pharmaceuticals Inc. | 2020-11-02 |
| 72485-0201-01 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (... | AZACITIDINE | Armas Pharmaceuticals Inc. | 2018-09-10 |
| 72572-0020-01 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (... | Azacitidine | Civica, Inc. | 2025-09-12 |
| 75907-0225-11 | 1 VIAL in 1 CARTON (75907-225-11) / 1 INJECTION, POWDER, LY... | Azacitidine | Dr. Reddy's Laboratories Inc. | 2025-03-01 |
| 83774-0102-01 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (... | AZACITIDINE | Pilnova Pharma Inc | 2024-03-14 |
Observed labelers:
Dr. Reddy's Laboratories Inc. (4) ·
BluePoint Laboratories (2) ·
Meitheal Pharmaceuticals Inc. (2) ·
Accord Healthcare Inc. (1) ·
Amneal Pharmaceuticals LLC (1) ·
Apotex Corp (1)
· +15 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J9025 | Azacitidine injection | 19 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.